Literature DB >> 10095979

The pharmacodynamics and efficacy of Implanon. An overview of the data.

H B Croxatto1, L Mäkäräinen.   

Abstract

Implanon is a long-acting reversible contraceptive method, consisting of a single rod that is applied subdermally. Ovulation inhibition was determined by serum progesterone (P) levels and ultrasound scanning (USS) of the ovaries. Ovarian function was further assessed by serum estradiol (E2) levels. The effects of Implanon on serum gonadotropin levels (follicle-stimulating hormone [FSH] and luteinizing hormone [LH]) and on cervical mucus were also investigated, by means of Insler scores and sperm penetration tests. The effect of the endometrium was assessed by endometrial biopsies and USS. The Pearl index was calculated over 13 studies performed according to Good Clinical Practice (GCP), including 1716 women using Implanon. Return of ovulation after implant removal was determined by P levels and USS of the ovaries. The contraceptive efficacy of Implanon was high, with zero pregnancies during 53,530 cycles (4103 woman-years), resulting in a Pearl index of 0.0 (95% confidence interval, 0.00-0.09). This was achieved by inhibition of ovulation, which was reflected by suppressed P levels, as the primary mode of action. Ovulation was inhibited, but otherwise ovarian activity was still present (follicle growth, E2 synthesis). The FSH serum concentrations were only slightly lower than preinsertion levels and LH surges were prevented. The viscosity of the cervical mucus was increased. The endometrium was thin but not atrophic; it showed primarily inactive or weak proliferation. Return of ovulation after removal of Implanon was rapid.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 10095979     DOI: 10.1016/s0010-7824(98)00118-8

Source DB:  PubMed          Journal:  Contraception        ISSN: 0010-7824            Impact factor:   3.375


  19 in total

1.  Economic analysis of long-term reversible contraceptives. Focus on Implanon.

Authors:  C J Phillips
Journal:  Pharmacoeconomics       Date:  2000-02       Impact factor: 4.981

2.  Relative cost effectiveness of Depo-Provera, Implanon, and Mirena in reversible long-term hormonal contraception in the UK.

Authors:  Susan J Varney; Julian F Guest
Journal:  Pharmacoeconomics       Date:  2004       Impact factor: 4.981

Review 3.  Subdermal implantable contraceptives versus other forms of reversible contraceptives or other implants as effective methods of preventing pregnancy.

Authors:  J Power; R French; F Cowan
Journal:  Cochrane Database Syst Rev       Date:  2007-07-18

4.  Comparison of plasma etonogestrel concentrations sampled from the contralateral-to-implant and ipsilateral-to-implant arms of contraceptive implant users.

Authors:  Alida M Gertz; Ian J Bishop; Boikhutso Simon; Kwana Lechiile; Opelo Badubi; Aamirah Mussa; Carolyn L Westhoff; Chelsea Morroni
Journal:  Contraception       Date:  2020-08-26       Impact factor: 3.375

Review 5.  Drug delivery for the treatment of endometriosis and uterine fibroids.

Authors:  David R Friend
Journal:  Drug Deliv Transl Res       Date:  2017-12       Impact factor: 4.617

6.  Hormonal contraceptive options for women with headache: a review of the evidence.

Authors:  Andrea G Edlow; Deborah Bartz
Journal:  Rev Obstet Gynecol       Date:  2010

7.  Cost effectiveness of contraceptives in the United States.

Authors:  James Trussell; Anjana M Lalla; Quan V Doan; Eileen Reyes; Lionel Pinto; Joseph Gricar
Journal:  Contraception       Date:  2008-09-25       Impact factor: 3.375

Review 8.  Risks and benefits, advantages and disadvantages of levonorgestrel-releasing contraceptive implants.

Authors:  Irving Sivin
Journal:  Drug Saf       Date:  2003       Impact factor: 5.606

9.  Examining the efficacy, safety, and patient acceptability of the etonogestrel implantable contraceptive.

Authors:  Heather Hohmann
Journal:  Patient Prefer Adherence       Date:  2009-11-03       Impact factor: 2.711

10.  Statement on pregnancy in pulmonary hypertension from the Pulmonary Vascular Research Institute.

Authors:  Anna R Hemnes; David G Kiely; Barbara A Cockrill; Zeenat Safdar; Victoria J Wilson; Manal Al Hazmi; Ioana R Preston; Mandy R MacLean; Tim Lahm
Journal:  Pulm Circ       Date:  2015-09       Impact factor: 3.017

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.